ALB vs LGVN · rev $1.74B vs rev $2.4M
Albemarle Corp (ALB) versus Longeveron LLC (LGVN) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Longeveron LLC (LGVN) is a biotechnology company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported LGVN revenue for 2024-12-31 was $2.4M. Net income was -$16.0M. Revenue was up 237.4% from 2023-12-31 to 2024-12-31. LGVN currently screens at market cap $26.5M.
ALB currently screens at market cap $8.00B. LGVN currently screens at market cap $26.5M.
Not investment advice. Open the ALB and LGVN stock pages for the full models.
Not investment advice.